mouse antibody against chick col2 Search Results


97
Developmental Studies Hybridoma Bank col2
Col2, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col2/product/Developmental Studies Hybridoma Bank
Average 97 stars, based on 1 article reviews
col2 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

94
Chondrex Inc mouse anti col 2
Mouse Anti Col 2, supplied by Chondrex Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti col 2/product/Chondrex Inc
Average 94 stars, based on 1 article reviews
mouse anti col 2 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Millipore anti-col2
Anti Col2, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-col2/product/Millipore
Average 90 stars, based on 1 article reviews
anti-col2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology col2
Col2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col2/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
col2 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology anti-col2 monoclonal antibody
Anti Col2 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-col2 monoclonal antibody/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
anti-col2 monoclonal antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher monoclonal mouse anti-col2
Analysis of image stained with anti-type 2 collagen antibody using Image J. The area of the entire implanted cell sheet regenerative area ( A ); and the positive cell area ( B ). % <t>COL2</t> area is shown as the percentage of ( B ) to ( A ). Bars: 500 μm.
Monoclonal Mouse Anti Col2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal mouse anti-col2/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
monoclonal mouse anti-col2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher goat anti-mouse igg-488
Analysis of image stained with anti-type 2 collagen antibody using Image J. The area of the entire implanted cell sheet regenerative area ( A ); and the positive cell area ( B ). % <t>COL2</t> area is shown as the percentage of ( B ) to ( A ). Bars: 500 μm.
Goat Anti Mouse Igg 488, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti-mouse igg-488/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
goat anti-mouse igg-488 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

86
Danaher Inc mouse primary anti col2 antibody
Analysis of image stained with anti-type 2 collagen antibody using Image J. The area of the entire implanted cell sheet regenerative area ( A ); and the positive cell area ( B ). % <t>COL2</t> area is shown as the percentage of ( B ) to ( A ). Bars: 500 μm.
Mouse Primary Anti Col2 Antibody, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse primary anti col2 antibody/product/Danaher Inc
Average 86 stars, based on 1 article reviews
mouse primary anti col2 antibody - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

96
Proteintech anti col2
Fig. 4. Bioenergetic-active exosomes promotes BMSC chondrogenic differentiation and chondrocyte’s homeostasis maintenance through the P2X7-mediated path- way. (A) Hematoxylin and eosin (H&E) (top)–, Toluidine blue (middle)–, Alcian blue (bottom)–stained sections of BMSC microspheres cocultured with N-EXO and Suc-EXO for 28 days. (B) Relative mRNA level of chondrogenic differentiation gene after stimulated by N-EXO and Suc-EXO for 7 days (bottom), 14 days (middle), and 21 days (top) in chondro- genic differentiation medium. (C) Relative mRNA level of <t>Col2,</t> ACAN, MMP9, and MMP13 of BMSCs in common medium. (D) The protein levels of MMP13, MMP9, and Col2 in BMSCs quantified by Western blot. (E) Relative mRNA level of PI3K (top), AKT (middle), and mTOR (down) after incubation with N-EXO, N-EXO, and KN62, Suc-EXO or Suc-EXO and KN62. (F) The protein levels of P2X7, P-mTOR, mTOR, P-S6K, S6K, P-AKT, and AKT in BMSCs quantified by Western blot. (G to I) Relative mRNA level of Col2 (G), ACAN (H), and MMP13 (I) in chondrocytes. (J) The protein levels of MMP13 and Col2 in chondrocytes quantified by Western blot. (K and L) Relative mRNA level of SIRT3 (K) and AMPK (L) in chondrocytes. (M) The protein levels of P2X7, SIRT3, p-AMPK, and AMPK in chondrocytes quantified by Western blot. Results in (B), (C), (E), (G) to (I), and (K) and (L) represent the mean ± SD (n = 3 biological repeats). Statistical analysis: *P < 0.05, **P < 0.01, and ***P < 0.001, analyzed using ANOVA with Tukey’s multiple comparisons test.
Anti Col2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti col2/product/Proteintech
Average 96 stars, based on 1 article reviews
anti col2 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

98
Abcam rabbit polyclonal anti col 2
Fig. 4. Bioenergetic-active exosomes promotes BMSC chondrogenic differentiation and chondrocyte’s homeostasis maintenance through the P2X7-mediated path- way. (A) Hematoxylin and eosin (H&E) (top)–, Toluidine blue (middle)–, Alcian blue (bottom)–stained sections of BMSC microspheres cocultured with N-EXO and Suc-EXO for 28 days. (B) Relative mRNA level of chondrogenic differentiation gene after stimulated by N-EXO and Suc-EXO for 7 days (bottom), 14 days (middle), and 21 days (top) in chondro- genic differentiation medium. (C) Relative mRNA level of <t>Col2,</t> ACAN, MMP9, and MMP13 of BMSCs in common medium. (D) The protein levels of MMP13, MMP9, and Col2 in BMSCs quantified by Western blot. (E) Relative mRNA level of PI3K (top), AKT (middle), and mTOR (down) after incubation with N-EXO, N-EXO, and KN62, Suc-EXO or Suc-EXO and KN62. (F) The protein levels of P2X7, P-mTOR, mTOR, P-S6K, S6K, P-AKT, and AKT in BMSCs quantified by Western blot. (G to I) Relative mRNA level of Col2 (G), ACAN (H), and MMP13 (I) in chondrocytes. (J) The protein levels of MMP13 and Col2 in chondrocytes quantified by Western blot. (K and L) Relative mRNA level of SIRT3 (K) and AMPK (L) in chondrocytes. (M) The protein levels of P2X7, SIRT3, p-AMPK, and AMPK in chondrocytes quantified by Western blot. Results in (B), (C), (E), (G) to (I), and (K) and (L) represent the mean ± SD (n = 3 biological repeats). Statistical analysis: *P < 0.05, **P < 0.01, and ***P < 0.001, analyzed using ANOVA with Tukey’s multiple comparisons test.
Rabbit Polyclonal Anti Col 2, supplied by Abcam, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti col 2/product/Abcam
Average 98 stars, based on 1 article reviews
rabbit polyclonal anti col 2 - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

90
Developmental Studies Hybridoma Bank mouse anti-human collagen type 2 (col2
Minimum expansion time frame to obtain chondrogenic hADSCs from the isolation phase. A Representative brightfield images of cryosections from pellet culture stained with SafraninO (in pink) and Haematoxylin (in purple) to identify cell’s nuclei. B Representative confocal images of cryosections from pellet immunostained with Phalloidin-RFP (Actin, in red), <t>Collagen</t> <t>type</t> <t>2</t> (Col 2, in cyan) and counterstained to detect cells nuclei (DAPI, in white). Superimposed channels are shown in the last row of panels (MERGE). For all the stainings, the cryosections were obtained from cells pelleted after 5 and 7 days of non-passaged proliferation, pushed into 3 weeks of chondrogenic differentiation. The calculated Collagen type 2 intensity from day 0 to day 21 in reported as Fold Increase (F.I.) in the day 21 panels of their corresponding groups
Mouse Anti Human Collagen Type 2 (Col2, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human collagen type 2 (col2/product/Developmental Studies Hybridoma Bank
Average 90 stars, based on 1 article reviews
mouse anti-human collagen type 2 (col2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

99
Thermo Fisher rabbit type ii collagen col2 polyclonal antibody pa1 26206
Minimum expansion time frame to obtain chondrogenic hADSCs from the isolation phase. A Representative brightfield images of cryosections from pellet culture stained with SafraninO (in pink) and Haematoxylin (in purple) to identify cell’s nuclei. B Representative confocal images of cryosections from pellet immunostained with Phalloidin-RFP (Actin, in red), <t>Collagen</t> <t>type</t> <t>2</t> (Col 2, in cyan) and counterstained to detect cells nuclei (DAPI, in white). Superimposed channels are shown in the last row of panels (MERGE). For all the stainings, the cryosections were obtained from cells pelleted after 5 and 7 days of non-passaged proliferation, pushed into 3 weeks of chondrogenic differentiation. The calculated Collagen type 2 intensity from day 0 to day 21 in reported as Fold Increase (F.I.) in the day 21 panels of their corresponding groups
Rabbit Type Ii Collagen Col2 Polyclonal Antibody Pa1 26206, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit type ii collagen col2 polyclonal antibody pa1 26206/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
rabbit type ii collagen col2 polyclonal antibody pa1 26206 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


Analysis of image stained with anti-type 2 collagen antibody using Image J. The area of the entire implanted cell sheet regenerative area ( A ); and the positive cell area ( B ). % COL2 area is shown as the percentage of ( B ) to ( A ). Bars: 500 μm.

Journal: Cartilage

Article Title: Regenerative Variability of Human Juvenile Chondrocyte Sheets From Different Cell Donors in an Athymic Rat Knee Chondral Defect Model

doi: 10.1177/19476035241277946

Figure Lengend Snippet: Analysis of image stained with anti-type 2 collagen antibody using Image J. The area of the entire implanted cell sheet regenerative area ( A ); and the positive cell area ( B ). % COL2 area is shown as the percentage of ( B ) to ( A ). Bars: 500 μm.

Article Snippet: Polyclonal goat anti-COL1 (1:200, SouthernBiotech, Birmingham, USA), monoclonal mouse anti-COL2 (1:200, 2B1.5, ThermoFisher, USA), and monoclonal rabbit anti-hVIM (1:200, SP20, Abcam) were used as primary antibodies.

Techniques: Staining

Scores of each system in all samples. The scores were arranged in order of modified O’Driscoll score. Bars sharing the same pattern represent samples from the same donor. Sample numbered 1, 3, and 5 represent the defect groups. ( A ) modified O’Driscoll score, ( B ) %COL1 area, ( C ) %COL2 area, and ( D ) COL1/2 ratios.

Journal: Cartilage

Article Title: Regenerative Variability of Human Juvenile Chondrocyte Sheets From Different Cell Donors in an Athymic Rat Knee Chondral Defect Model

doi: 10.1177/19476035241277946

Figure Lengend Snippet: Scores of each system in all samples. The scores were arranged in order of modified O’Driscoll score. Bars sharing the same pattern represent samples from the same donor. Sample numbered 1, 3, and 5 represent the defect groups. ( A ) modified O’Driscoll score, ( B ) %COL1 area, ( C ) %COL2 area, and ( D ) COL1/2 ratios.

Article Snippet: Polyclonal goat anti-COL1 (1:200, SouthernBiotech, Birmingham, USA), monoclonal mouse anti-COL2 (1:200, 2B1.5, ThermoFisher, USA), and monoclonal rabbit anti-hVIM (1:200, SP20, Abcam) were used as primary antibodies.

Techniques: Modification

Scatter plot of the correlation between modified O’Driscoll score and %COL 1 area ( A ), %COL 2 area ( B ), and COL2/1 ratio ( C ). Modified O’Driscoll score correlated significantly with each score (P<0.01).

Journal: Cartilage

Article Title: Regenerative Variability of Human Juvenile Chondrocyte Sheets From Different Cell Donors in an Athymic Rat Knee Chondral Defect Model

doi: 10.1177/19476035241277946

Figure Lengend Snippet: Scatter plot of the correlation between modified O’Driscoll score and %COL 1 area ( A ), %COL 2 area ( B ), and COL2/1 ratio ( C ). Modified O’Driscoll score correlated significantly with each score (P<0.01).

Article Snippet: Polyclonal goat anti-COL1 (1:200, SouthernBiotech, Birmingham, USA), monoclonal mouse anti-COL2 (1:200, 2B1.5, ThermoFisher, USA), and monoclonal rabbit anti-hVIM (1:200, SP20, Abcam) were used as primary antibodies.

Techniques: Modification

Comparison of each score between groups. ( A ) modified O’Driscoll score, ( B ) %COL1 area, ( C ) %COL2 area, ( D ) COL2/1 ratio. *<0.01, **<0.05.

Journal: Cartilage

Article Title: Regenerative Variability of Human Juvenile Chondrocyte Sheets From Different Cell Donors in an Athymic Rat Knee Chondral Defect Model

doi: 10.1177/19476035241277946

Figure Lengend Snippet: Comparison of each score between groups. ( A ) modified O’Driscoll score, ( B ) %COL1 area, ( C ) %COL2 area, ( D ) COL2/1 ratio. *<0.01, **<0.05.

Article Snippet: Polyclonal goat anti-COL1 (1:200, SouthernBiotech, Birmingham, USA), monoclonal mouse anti-COL2 (1:200, 2B1.5, ThermoFisher, USA), and monoclonal rabbit anti-hVIM (1:200, SP20, Abcam) were used as primary antibodies.

Techniques: Comparison, Modification

Fig. 4. Bioenergetic-active exosomes promotes BMSC chondrogenic differentiation and chondrocyte’s homeostasis maintenance through the P2X7-mediated path- way. (A) Hematoxylin and eosin (H&E) (top)–, Toluidine blue (middle)–, Alcian blue (bottom)–stained sections of BMSC microspheres cocultured with N-EXO and Suc-EXO for 28 days. (B) Relative mRNA level of chondrogenic differentiation gene after stimulated by N-EXO and Suc-EXO for 7 days (bottom), 14 days (middle), and 21 days (top) in chondro- genic differentiation medium. (C) Relative mRNA level of Col2, ACAN, MMP9, and MMP13 of BMSCs in common medium. (D) The protein levels of MMP13, MMP9, and Col2 in BMSCs quantified by Western blot. (E) Relative mRNA level of PI3K (top), AKT (middle), and mTOR (down) after incubation with N-EXO, N-EXO, and KN62, Suc-EXO or Suc-EXO and KN62. (F) The protein levels of P2X7, P-mTOR, mTOR, P-S6K, S6K, P-AKT, and AKT in BMSCs quantified by Western blot. (G to I) Relative mRNA level of Col2 (G), ACAN (H), and MMP13 (I) in chondrocytes. (J) The protein levels of MMP13 and Col2 in chondrocytes quantified by Western blot. (K and L) Relative mRNA level of SIRT3 (K) and AMPK (L) in chondrocytes. (M) The protein levels of P2X7, SIRT3, p-AMPK, and AMPK in chondrocytes quantified by Western blot. Results in (B), (C), (E), (G) to (I), and (K) and (L) represent the mean ± SD (n = 3 biological repeats). Statistical analysis: *P < 0.05, **P < 0.01, and ***P < 0.001, analyzed using ANOVA with Tukey’s multiple comparisons test.

Journal: Science advances

Article Title: Bioenergetic-active exosomes for cartilage regeneration and homeostasis maintenance.

doi: 10.1126/sciadv.adp7872

Figure Lengend Snippet: Fig. 4. Bioenergetic-active exosomes promotes BMSC chondrogenic differentiation and chondrocyte’s homeostasis maintenance through the P2X7-mediated path- way. (A) Hematoxylin and eosin (H&E) (top)–, Toluidine blue (middle)–, Alcian blue (bottom)–stained sections of BMSC microspheres cocultured with N-EXO and Suc-EXO for 28 days. (B) Relative mRNA level of chondrogenic differentiation gene after stimulated by N-EXO and Suc-EXO for 7 days (bottom), 14 days (middle), and 21 days (top) in chondro- genic differentiation medium. (C) Relative mRNA level of Col2, ACAN, MMP9, and MMP13 of BMSCs in common medium. (D) The protein levels of MMP13, MMP9, and Col2 in BMSCs quantified by Western blot. (E) Relative mRNA level of PI3K (top), AKT (middle), and mTOR (down) after incubation with N-EXO, N-EXO, and KN62, Suc-EXO or Suc-EXO and KN62. (F) The protein levels of P2X7, P-mTOR, mTOR, P-S6K, S6K, P-AKT, and AKT in BMSCs quantified by Western blot. (G to I) Relative mRNA level of Col2 (G), ACAN (H), and MMP13 (I) in chondrocytes. (J) The protein levels of MMP13 and Col2 in chondrocytes quantified by Western blot. (K and L) Relative mRNA level of SIRT3 (K) and AMPK (L) in chondrocytes. (M) The protein levels of P2X7, SIRT3, p-AMPK, and AMPK in chondrocytes quantified by Western blot. Results in (B), (C), (E), (G) to (I), and (K) and (L) represent the mean ± SD (n = 3 biological repeats). Statistical analysis: *P < 0.05, **P < 0.01, and ***P < 0.001, analyzed using ANOVA with Tukey’s multiple comparisons test.

Article Snippet: 10, eadp7872 (2024) 18 October 2024 16 of 18 Proteintech, China), anti- MMP13 (1:1000; rabbit polyclonal, Proteintech, China), anti- Col2 (1:1000; rabbit polyclonal, Proteintech, China), anti–phospho- AMPK (1:1000; rabbit polyclonal, Proteintech, China), anti- SIRT3 (1:1000; rabbit polyclonal, ABclonal, China), anti- AMPK (1:1000; rabbit polyclonal, Proteintech, China), anti- P2RX7 (1:1000, rabbit polyclonal, ABclonal, China), anti- AKT(1:1000; rabbit monoclonal, Cell Signaling Technology (CST), USA), anti–phospho- AKT (Ser473) (1:2000; rabbit monoclonal, CST, USA), anti- calnexin (1:1000; rabbit polyclonal, Proteintech, China), anti- S6K (1:2000; rabbit monoclonal, Proteintech, China), anti–phospho- S6K (Thr389) (1:1000; rabbit monoclonal, CST, USA), anti–β- ACTIN (1:20,000; mouse monoclonal, Proteintech, China), and anti- GAPDH (1:50,000, mouse monoclonal, Proteintech, China).

Techniques: Staining, Western Blot, Incubation

Fig. 7. Immunohistochemical and immunofluorescence assessment of cartilage regeneration. (A) Immunohistochemical staining for Col2, ACAN, MMP9, and MMP13. Relative staining intensity of ACAN (B), Col2 (C), MMP9 (D), and MMP13 (E) in cartilage samples at 6 and 12 weeks. (F) Immunofluorescence staining for SIRT3 and Col2 at 12 weeks. Results in (B) to (E) represent the mean ± SD (n = 3 technical repeats). Statistical analysis: **P < 0.01 and ***P < 0.001, analyzed using ANOVA with Tukey’s multiple comparisons test.

Journal: Science advances

Article Title: Bioenergetic-active exosomes for cartilage regeneration and homeostasis maintenance.

doi: 10.1126/sciadv.adp7872

Figure Lengend Snippet: Fig. 7. Immunohistochemical and immunofluorescence assessment of cartilage regeneration. (A) Immunohistochemical staining for Col2, ACAN, MMP9, and MMP13. Relative staining intensity of ACAN (B), Col2 (C), MMP9 (D), and MMP13 (E) in cartilage samples at 6 and 12 weeks. (F) Immunofluorescence staining for SIRT3 and Col2 at 12 weeks. Results in (B) to (E) represent the mean ± SD (n = 3 technical repeats). Statistical analysis: **P < 0.01 and ***P < 0.001, analyzed using ANOVA with Tukey’s multiple comparisons test.

Article Snippet: 10, eadp7872 (2024) 18 October 2024 16 of 18 Proteintech, China), anti- MMP13 (1:1000; rabbit polyclonal, Proteintech, China), anti- Col2 (1:1000; rabbit polyclonal, Proteintech, China), anti–phospho- AMPK (1:1000; rabbit polyclonal, Proteintech, China), anti- SIRT3 (1:1000; rabbit polyclonal, ABclonal, China), anti- AMPK (1:1000; rabbit polyclonal, Proteintech, China), anti- P2RX7 (1:1000, rabbit polyclonal, ABclonal, China), anti- AKT(1:1000; rabbit monoclonal, Cell Signaling Technology (CST), USA), anti–phospho- AKT (Ser473) (1:2000; rabbit monoclonal, CST, USA), anti- calnexin (1:1000; rabbit polyclonal, Proteintech, China), anti- S6K (1:2000; rabbit monoclonal, Proteintech, China), anti–phospho- S6K (Thr389) (1:1000; rabbit monoclonal, CST, USA), anti–β- ACTIN (1:20,000; mouse monoclonal, Proteintech, China), and anti- GAPDH (1:50,000, mouse monoclonal, Proteintech, China).

Techniques: Immunohistochemical staining, Immunofluorescence, Staining

Minimum expansion time frame to obtain chondrogenic hADSCs from the isolation phase. A Representative brightfield images of cryosections from pellet culture stained with SafraninO (in pink) and Haematoxylin (in purple) to identify cell’s nuclei. B Representative confocal images of cryosections from pellet immunostained with Phalloidin-RFP (Actin, in red), Collagen type 2 (Col 2, in cyan) and counterstained to detect cells nuclei (DAPI, in white). Superimposed channels are shown in the last row of panels (MERGE). For all the stainings, the cryosections were obtained from cells pelleted after 5 and 7 days of non-passaged proliferation, pushed into 3 weeks of chondrogenic differentiation. The calculated Collagen type 2 intensity from day 0 to day 21 in reported as Fold Increase (F.I.) in the day 21 panels of their corresponding groups

Journal: Tissue Engineering and Regenerative Medicine

Article Title: Towards Clinical Translation of In Situ Cartilage Engineering Strategies: Optimizing the Critical Facets of a Cell-Laden Hydrogel Therapy

doi: 10.1007/s13770-022-00487-9

Figure Lengend Snippet: Minimum expansion time frame to obtain chondrogenic hADSCs from the isolation phase. A Representative brightfield images of cryosections from pellet culture stained with SafraninO (in pink) and Haematoxylin (in purple) to identify cell’s nuclei. B Representative confocal images of cryosections from pellet immunostained with Phalloidin-RFP (Actin, in red), Collagen type 2 (Col 2, in cyan) and counterstained to detect cells nuclei (DAPI, in white). Superimposed channels are shown in the last row of panels (MERGE). For all the stainings, the cryosections were obtained from cells pelleted after 5 and 7 days of non-passaged proliferation, pushed into 3 weeks of chondrogenic differentiation. The calculated Collagen type 2 intensity from day 0 to day 21 in reported as Fold Increase (F.I.) in the day 21 panels of their corresponding groups

Article Snippet: After washing, samples were dropped in blocking solution (10% goat serum diluted in PBT) for 60 min and then incubated overnight at 4 °C with mouse anti-human Collagen type 2 (Col2) (#II6B3, DSHB) and goat anti-human Collagen type 1 (Col1) (# sc8784, Santa Cruz Biotechnology).

Techniques: Isolation, Staining

Assessment of minimal hADSCs concentration required for chondrogenesis in cell-laden hydrogel bioscaffolds. A Representative confocal images of cryosections from bioscaffolds from the 3 different hADSCs/ml groups, assessed using immunostaining for DAPI, Actin and Collagen type 2 (Col 2). The cryosections has been obtained by cutting the samples along the z axis to provide spatial information from the top to the bottom of the bioscaffolds. B Superimposed high magnification of the selected white square areas (I and II) in ( A ). C The graphs show the quantification expressed as fold change relative to 1.25 hADCSs/ml group at day 21 post chondrogenesis. The Collagen type 2 (Col 2) intensity signal was calculated and averaged from 16 different ROI from the Collagen II stained cryosections (see Figure S7). D The graphs show the quantification of Glycosaminoglycan (GAG) content measured via the normalisation of GAG over total DNA present in the processed bioscaffolds and expressed as fold change relative to 1.25 hADSCs/ml group at day 21 post chondrogenesis. E Chondrogenic gene expression analysis: the bar graphs represent the fold changes calculated with 2 ΔΔCΤ method of Collagen type 2A1 (COL2A1), Aggrecan (ACAN), Sox9 (SOX9) and Collagen type 1A2 (COL1A2) markers in RT-qPCR assay, relative to 1.25 hADSCs/ml group at day 21 post chondrogenesis. GAPDH was used as the housekeeping gene. Graph bars represent standard error margin between three biological replicates. Statistical analysis was performed using an unpaired t-test

Journal: Tissue Engineering and Regenerative Medicine

Article Title: Towards Clinical Translation of In Situ Cartilage Engineering Strategies: Optimizing the Critical Facets of a Cell-Laden Hydrogel Therapy

doi: 10.1007/s13770-022-00487-9

Figure Lengend Snippet: Assessment of minimal hADSCs concentration required for chondrogenesis in cell-laden hydrogel bioscaffolds. A Representative confocal images of cryosections from bioscaffolds from the 3 different hADSCs/ml groups, assessed using immunostaining for DAPI, Actin and Collagen type 2 (Col 2). The cryosections has been obtained by cutting the samples along the z axis to provide spatial information from the top to the bottom of the bioscaffolds. B Superimposed high magnification of the selected white square areas (I and II) in ( A ). C The graphs show the quantification expressed as fold change relative to 1.25 hADCSs/ml group at day 21 post chondrogenesis. The Collagen type 2 (Col 2) intensity signal was calculated and averaged from 16 different ROI from the Collagen II stained cryosections (see Figure S7). D The graphs show the quantification of Glycosaminoglycan (GAG) content measured via the normalisation of GAG over total DNA present in the processed bioscaffolds and expressed as fold change relative to 1.25 hADSCs/ml group at day 21 post chondrogenesis. E Chondrogenic gene expression analysis: the bar graphs represent the fold changes calculated with 2 ΔΔCΤ method of Collagen type 2A1 (COL2A1), Aggrecan (ACAN), Sox9 (SOX9) and Collagen type 1A2 (COL1A2) markers in RT-qPCR assay, relative to 1.25 hADSCs/ml group at day 21 post chondrogenesis. GAPDH was used as the housekeeping gene. Graph bars represent standard error margin between three biological replicates. Statistical analysis was performed using an unpaired t-test

Article Snippet: After washing, samples were dropped in blocking solution (10% goat serum diluted in PBT) for 60 min and then incubated overnight at 4 °C with mouse anti-human Collagen type 2 (Col2) (#II6B3, DSHB) and goat anti-human Collagen type 1 (Col1) (# sc8784, Santa Cruz Biotechnology).

Techniques: Concentration Assay, Immunostaining, Staining, Expressing, Quantitative RT-PCR

In situ stem cells-laden hydrogel therapy in a rabbit in vivo cartilage repair model. A Representative macroscopic pictures (Macro) and images from Haematoxylin and Eosin (H&E) stained paraffin sections from explanted samples of the indicated groups. Representative confocal images of paraffin sections from explanted samples of the indicated groups assessed using immunostaining for Collagen type 2 (Col 2, in cyan) and Collagen type 1 (Col 1, in red). Overimposed images of the two channels are shown in the Merge raw. B The graph shows the macroscopic score using the International Cartilage Repair Society (ICRS) system for the indicated groups, calculated at the end of the 8 weeks study on the explants. C The graph shows the microscopic score calculated at the end of the 8 weeks study on the HandE and Col1 and 2 stained paraffin sections. D The graph shows the percentage of the Collagen 1 (Col 1) and Collagen 2 (Col 2) positive areas. Graph bars represents the mean with standard deviation of 4 different regions along the entire diameter of the defect for each sample analysed calculated at the end of the 8 weeks study on the immunostained paraffin sections. E The graph shows the biomechanical evaluation using atomic force microscopy calculated at the end of the 8 weeks study on the explants and expressed as Young Modulus (kPa kilopascals). Statistical analysis was performed using unpaired t-test

Journal: Tissue Engineering and Regenerative Medicine

Article Title: Towards Clinical Translation of In Situ Cartilage Engineering Strategies: Optimizing the Critical Facets of a Cell-Laden Hydrogel Therapy

doi: 10.1007/s13770-022-00487-9

Figure Lengend Snippet: In situ stem cells-laden hydrogel therapy in a rabbit in vivo cartilage repair model. A Representative macroscopic pictures (Macro) and images from Haematoxylin and Eosin (H&E) stained paraffin sections from explanted samples of the indicated groups. Representative confocal images of paraffin sections from explanted samples of the indicated groups assessed using immunostaining for Collagen type 2 (Col 2, in cyan) and Collagen type 1 (Col 1, in red). Overimposed images of the two channels are shown in the Merge raw. B The graph shows the macroscopic score using the International Cartilage Repair Society (ICRS) system for the indicated groups, calculated at the end of the 8 weeks study on the explants. C The graph shows the microscopic score calculated at the end of the 8 weeks study on the HandE and Col1 and 2 stained paraffin sections. D The graph shows the percentage of the Collagen 1 (Col 1) and Collagen 2 (Col 2) positive areas. Graph bars represents the mean with standard deviation of 4 different regions along the entire diameter of the defect for each sample analysed calculated at the end of the 8 weeks study on the immunostained paraffin sections. E The graph shows the biomechanical evaluation using atomic force microscopy calculated at the end of the 8 weeks study on the explants and expressed as Young Modulus (kPa kilopascals). Statistical analysis was performed using unpaired t-test

Article Snippet: After washing, samples were dropped in blocking solution (10% goat serum diluted in PBT) for 60 min and then incubated overnight at 4 °C with mouse anti-human Collagen type 2 (Col2) (#II6B3, DSHB) and goat anti-human Collagen type 1 (Col1) (# sc8784, Santa Cruz Biotechnology).

Techniques: In Situ, In Vivo, Staining, Immunostaining, Standard Deviation, Microscopy